Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression

American Journal of Pathology

Volumn 160, Issue 3, 2002, Pages 1009-1019

  Straume, Oddbjørn ^a   Akslen, Lars Andreas ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; EPHRIN; EPHRIN A1; EPHRIN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0036118459     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64922-X     Document Type: Article

References (91)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Angiogenesis and cancer metastasis
4. Clinical applications of angiogenic growth factors and their inhibitors
5. Antiangiogenic agents and their promising potential in combined therapy
6. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
7. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: A population-based endometrial carcinoma study
8. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
9. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma
10. Angiogenesis during tumor progression in human malignant melanoma
11. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas
12. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin
13. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase
14. Expression of vascular endothelial growth factor, its receptors (flt-1, kdr) and tsp-1 related to microvessel density and patient outcome in vertical growth phase melanomas
15. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
16. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry
17. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: Role of epithelial cell kinase (Eck/EphA2)
18. Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma
19. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
20. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis
21. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
22. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
23. Molecular and biological properties of vascular endothelial growth factor
24. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
25. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis
26. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer
27. Thrombospondins I and II messenger RNA expression in lung carcinoma: Relationship with p53 alterations, angiogenic growth factors, and vascular density
28. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
29. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
30. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
31. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma
32. Expression of growth factors, growth inhibiting factors, their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops
33. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
34. Human melanoma ceils but not normal melanocytes express vascular endothelial growth factor receptors
35. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours
36. Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR
37. bFGF and tumor angiogenesis - Back in the limelight?
38. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth
39. Fibroblast growth factors are required for efficient tumor angiogenesis
40. Interleukin-8 as a macrophage-derived mediator of angiogenesis
41. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis
42. Role of interleukin-8 in tumor growth and metastasis of human melanoma
43. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
44. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
45. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer
46. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth
47. The Eph family in the patterning of neural development
48. The Eph family of receptors
49. Cell signalling Receptor orphans find a family
50. Tyrosine phosphorylation of L1 family adhesion molecules: Implication of the Eph kinase Cek5
51. A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein
52. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF
53. Up-regulation of ephrin-A1 during melanoma progression
54. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells
55. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts
56. Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo
57. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis
58. Enhanced expression of vascular endothelial growth factor in metastatic melanoma
59. bFGF as an autocrine growth factor for human melanomas
60. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor
61. Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma
62. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes
63. Human melanoma progression in skin reconstructs: Biological significance of bFGF
64. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor
65. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma
66. Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin
67. IL-8 expression in malignant melanoma: Implications in growth and metastasis
68. Protein B61 as a new growth factor: Expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression
69. Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma
70. Melanocytic tumors of the skin
71. Tissue microarrays for high-throughput molecular profiling of tumor specimens
72. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors
73. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade
74. Regression models and life-tables
75. Angiogenesis is prognostically important in vertical growth phase melanomas
76. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin
77. The prognostic significance of basic fibroblast growth factor in cutaneous malignant melanoma
78. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor
79. Basic fibroblast growth factor is a morphogenic modulator in kidney vessel development
80. Expression and function of angiopoietin-1 in breast cancer
81. The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression
82. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
83. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia
84. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
85. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
86. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
87. The vascular endothelial enclothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
88. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1
89. Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat
90. Molecular determinants of ovarian cancer plasticity